Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enteroendocrine L-cell nutrient sensing pathways represent the integrated molecular systems through which specialized intestinal cells detect dietary intake and regulate metabolic homeostasis [2, 3]. These pathways involve a diverse array of sensors, including G protein-coupled receptors (GPCRs) such as GPR119, FFAR1 (GPR40), FFAR4 (GPR120), and TGR5 (GPBAR1), as well as nutrient transporters like the sodium-glucose co-transporter 1 (SGLT1) [2, 4]. Upon activation by luminal nutrients—including glucose, long-chain fatty acids, and amino acids—these sensors trigger intracellular signaling cascades that lead to the secretion of the incretin hormones glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) [4, 5]. These hormones are vital for enhancing glucose-dependent insulin secretion, slowing gastric emptying, and promoting satiety [2, 4]. Dysregulation of these sensing mechanisms is a hallmark of metabolic disorders such as type 2 diabetes and obesity, where the postprandial incretin response is often blunted [1, 2]. Pharmacological strategies targeting these pathways, such as GPR119 agonists or TGR5 modulators, aim to restore or enhance endogenous hormone release to improve glycemic control and support weight management [2, 4]. This approach offers a potential therapeutic alternative to exogenous GLP-1 receptor agonists by leveraging the body's natural hormone production mechanisms [2].
Activation of G protein-coupled receptors (GPR119, FFAR1, FFAR4, TGR5) and nutrient transporters (SGLT1) on the L-cell membrane, triggering intracellular signaling (cAMP, Ca2+) that leads to the exocytosis of GLP-1 and PYY [2, 4].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enteroendocrine L-cell nutrient sensing pathways.